- Home
- CDTX vs NMM Comparison
CDTX vs NMM Comparison
Compare CDTX & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- NMM
- Stock Information
- Founded
- CDTX 2012
- NMM 2007
- Country
- CDTX United States
- NMM Greece
- Employees
- CDTX N/A
- NMM N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- NMM Marine Transportation
- Sector
- CDTX Health Care
- NMM Consumer Discretionary
- Exchange
- CDTX Nasdaq
- NMM Nasdaq
- Market Cap
- CDTX 1.6B
- NMM 1.3B
- IPO Year
- CDTX 2015
- NMM 2007
- Fundamental
- Price
- CDTX $101.51
- NMM $44.57
- Analyst Decision
- CDTX Strong Buy
- NMM
- Analyst Count
- CDTX 11
- NMM 0
- Target Price
- CDTX $91.60
- NMM N/A
- AVG Volume (30 Days)
- CDTX 1.2M
- NMM 114.0K
- Earning Date
- CDTX 11-06-2025
- NMM 11-04-2025
- Dividend Yield
- CDTX N/A
- NMM 0.45%
- EPS Growth
- CDTX N/A
- NMM N/A
- EPS
- CDTX N/A
- NMM 10.24
- Revenue
- CDTX N/A
- NMM $1,305,026,000.00
- Revenue This Year
- CDTX N/A
- NMM N/A
- Revenue Next Year
- CDTX N/A
- NMM $9.93
- P/E Ratio
- CDTX N/A
- NMM $4.35
- Revenue Growth
- CDTX N/A
- NMM N/A
- 52 Week Low
- CDTX $10.14
- NMM $28.37
- 52 Week High
- CDTX $106.63
- NMM $63.92
- Technical
- Relative Strength Index (RSI)
- CDTX 73.64
- NMM 38.90
- Support Level
- CDTX $96.35
- NMM $44.06
- Resistance Level
- CDTX $106.63
- NMM $45.54
- Average True Range (ATR)
- CDTX 6.77
- NMM 1.12
- MACD
- CDTX 1.87
- NMM -0.53
- Stochastic Oscillator
- CDTX 87.48
- NMM 20.68
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through the chartering of vessels and voyage contracts. Geographically, it generates majority revenue from Asia.